Díaz Francisco Javier León, Aguilar José Luis Fernández, Pérez Belinda Sánchez, Casado Custodia Montiel, Narváez José Manuel Aranda, Daga José Antonio Pérez, Muñoz Miguel Ángel Suárez, Santoyo Julio Santoyo
Liver Transplant Unit, Regional Hospital, Málaga, Spain.
Gastroenterol Hepatol Bed Bench. 2017 Summer;10(3):173-177.
The inclusion of elderly donors can increase the pool of organs available for transplant.
To compare clinical outcomes and survival rates in patients who received livers from donors aged ≥ 80 years vs. younger donors.
We considered all liver transplantations performed in our unit between January 2006 and January 2015. Twelve patients received liver from a cadaveric donor aged ≥ 80 years (study group) and their outcomes were compared with those of patients who received liver from a younger donor (control group). This study was carried out to analyze the characteristics of donors and recipients, as well as the clinical course and survival of recipients.
Statistically significant differences were observed in donors' age (55.6 ± 14.4 vs. 82.7 ± 2.7 years, p < 0.001), donors' ICU stay (p = 0.008), donors' ALT levels (p = 0.009) and donors' AST levels (p = 0.01). Statistically significant differences were found in ischemia time (p < 0.05). In total, 8.3% of the recipients of liver from a donor aged < 80 required retransplantation vs. 25% of recipients of donor's ≥ 80 years. Patient survival at one, three and five years was 89%, 78.6% and 74.5%, respectively vs. 83.4%, 79.4% and 59.6% for the study group.
Livers from older donors can be safely used for transplantation with acceptable patient survival rates. However, graft survival rates are lower for recipients of livers from older donors as compared to younger donors, and survival only increased with retransplantation.
纳入老年供体可增加可供移植的器官库。
比较接受年龄≥80岁供体肝脏的患者与接受年轻供体肝脏的患者的临床结局和生存率。
我们纳入了2006年1月至2015年1月在本单位进行的所有肝移植手术。12例患者接受了年龄≥80岁的尸体供体肝脏(研究组),并将其结局与接受年轻供体肝脏的患者(对照组)进行比较。本研究旨在分析供体和受体的特征,以及受体的临床病程和生存率。
供体年龄(55.6±14.4岁对82.7±2.7岁,p<0.001)、供体在重症监护病房的住院时间(p=0.008)、供体谷丙转氨酶水平(p=0.009)和供体谷草转氨酶水平(p=0.01)存在统计学显著差异。缺血时间存在统计学显著差异(p<0.05)。总体而言,接受年龄<80岁供体肝脏的受体中有8.3%需要再次移植,而接受年龄≥80岁供体肝脏的受体中这一比例为25%。对照组患者1年、3年和5年的生存率分别为89%、78.6%和74.5%,研究组分别为83.4%、79.4%和59.6%。
老年供体的肝脏可安全用于移植,患者生存率可接受。然而,与年轻供体相比,接受老年供体肝脏的受体的移植物生存率较低,且只有通过再次移植生存率才会提高。